UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Fibrinolysis and bleeding of unknown cause

Research and practice in thrombosis and haemostasis, 2021-05, Vol.5 (4), p.e12511-n/a, Article e12511

2021

Link zum Volltext

Verfügbarkeit prüfen

Altered platelet proteome in lupus anticoagulant (LA)-positive patients-protein disulfide isomerase and NETosis as new players in LA-related thrombosis

Experimental and Molecular Medicine, 2020, 52(0), , pp.1-13

2020

Link zum Volltext

Verfügbarkeit prüfen

P1623: LOW LEVELS OF 25(OH) VITAMIN D IN ADULT PRIMARY ITP PATIENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e3847359-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

P1625: CLINICAL AND LABORATORY CHARACTERISTICS OF ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN EASTERN AUSTRIA

HemaSphere, 2023-08, Vol.7 (S3), p.e4496821-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause

International journal of laboratory hematology, 2024-05, Vol.46 (S1), p.27-33

2024

Link zum Volltext

Verfügbarkeit prüfen

American Society of Hematology 2020 Podcast Collection: Immune Thrombocytopenia

Advances in therapy, 2021-06, Vol.38 (Suppl 1), p.20-25

2021

Link zum Volltext

Verfügbarkeit prüfen

Natural anticoagulants: A missing link in mild to moderate bleeding tendencies

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-09, Vol.27 (5), p.701-709

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank

Journal of thrombosis and haemostasis, 2023-07, Vol.21 (7), p.1757-1768

2023

Link zum Volltext

Verfügbarkeit prüfen

Activated protein C and free protein S in patients with mild to moderate bleeding disorders

Thrombosis research, 2024-03, Vol.235, p.98-106

2024

Link zum Volltext

Verfügbarkeit prüfen

Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out

Research and practice in thrombosis and haemostasis, 2023-11, Vol.7 (8), p.102242-102242, Article 102242

2023

Link zum Volltext

Verfügbarkeit prüfen

Repeated Testing Unfolds the Challenge of Diagnosing Von Willebrand Disease: Longitudinal Data from the Vienna Bleeding Biobank

Blood, 2022-11, Vol.140 (Supplement 1), p.8433-8434

2022

Link zum Volltext

Verfügbarkeit prüfen

The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders

Journal of thrombosis and haemostasis, 2024-01, Vol.22 (1), p.101-111

2024

Link zum Volltext

Verfügbarkeit prüfen

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Blood, 2015-05, Vol.125 (22), p.3477-3483

2015

Link zum Volltext

Verfügbarkeit prüfen

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Blood, 2021-11, Vol.138 (Supplement 1), p.290-290

2021

Link zum Volltext

Verfügbarkeit prüfen

Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie

Oncology research and treatment, 2023-04, Vol.46 (Suppl 1), p.7-56

2023

Link zum Volltext

Verfügbarkeit prüfen

The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency

European journal of internal medicine, 2020-08, Vol.78, p.34-40

2020

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals

Rheumatology (Oxford, England), 2021-04, Vol.60 (4), p.1687-1699

2021

Link zum Volltext

Verfügbarkeit prüfen

Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause

Journal of thrombosis and haemostasis, 2019-09, Vol.17 (9), p.1478-1488

2019

Link zum Volltext

Verfügbarkeit prüfen

Delayed Plasma Clot Lysis in Adult Patients with Primary Immune Thrombocytopenia (ITP)

Blood, 2021-11, Vol.138 (Supplement 1), p.3162-3162

2021

Link zum Volltext

Verfügbarkeit prüfen

Thrombomodulin in patients with mild to moderate bleeding tendency

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-11, Vol.27 (6), p.1028-1036

2021

Link zum Volltext

Verfügbarkeit prüfen

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Blood, 2019-11, Vol.134 (Supplement_1), p.1135-1135

2019

Link zum Volltext

Verfügbarkeit prüfen

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia

Thrombosis research, 2023-03, Vol.223, p.102-110

2023

Link zum Volltext

Verfügbarkeit prüfen

Association of ABO Blood Group with Bleeding Severity in Patients with Bleeding of Unknown Cause

Blood, 2020-11, Vol.136 (Supplement 1), p.16-18

2020

Link zum Volltext

Verfügbarkeit prüfen

Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis

Annals of hematology, 2019-02, Vol.98 (2), p.313-319

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(44)

Sprache

Englisch
(43)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Fibrinolysis and bleeding of unknown cause

Altered platelet proteome in lupus anticoagulant (LA)-positive patients-protein disulfide isomerase and NETosis as new players in LA-related thrombosis

P1623: LOW LEVELS OF 25(OH) VITAMIN D IN ADULT PRIMARY ITP PATIENTS

P1625: CLINICAL AND LABORATORY CHARACTERISTICS OF ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN EASTERN AUSTRIA

How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause

American Society of Hematology 2020 Podcast Collection: Immune Thrombocytopenia

Natural anticoagulants: A missing link in mild to moderate bleeding tendencies

Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank

Activated protein C and free protein S in patients with mild to moderate bleeding disorders

Investigating patients for bleeding disorders when most of the "usual" ones have been ruled out

Repeated Testing Unfolds the Challenge of Diagnosing Von Willebrand Disease: Longitudinal Data from the Vienna Bleeding Biobank

The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders

Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS)

Renal Function and Risk of Arterial Thrombotic Events in Patients Positive for Lupus Anticoagulant

Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders

Expertenreport Immunthrombozytopenie – Aktuelle Diagnostik und Therapie

The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency

Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals

Thrombin‐generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause

Delayed Plasma Clot Lysis in Adult Patients with Primary Immune Thrombocytopenia (ITP)

Thrombomodulin in patients with mild to moderate bleeding tendency

Factor VIII Levels in Blood Group O and Non-O in Patients with Non-Severe Haemophilia a

Platelet function and soluble P-selectin in patients with primary immune thrombocytopenia

Association of ABO Blood Group with Bleeding Severity in Patients with Bleeding of Unknown Cause

Low extracellular vesicle–associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis

Suchergebnisse filtern